LXRX / Lexicon Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Insider Trading Chart

Insider Roster and Profitability Metrics

This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings. Additionally, when possible we provide the historical trade performance for the insider. The historical trade performance is a weighted average of the performance of actual open-market purchase transactions made by the insider. For more information on how this is calculated, watch this YouTube webinar.

See our leaderboard of most profitable insider traders.

Report errors via our new Insider Auditing Tool

Track Records of Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in LXRX / Lexicon Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical .

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2023-11-16	COATS LONNEL	90,000	1.0533	90,000	1.0533	94,797	91	3.5800	227,403	239.88
2023-11-13	Amouyal Philippe	200,000	1.0076	200,000	1.0076	201,520
2023-11-10	COATS LONNEL	10,000	1.0100	10,000	1.0100	10,100
2023-10-12	DEBBANE RAYMOND	148,820	1.0335	148,820	1.0335	153,805
2023-10-11	DEBBANE RAYMOND	342,874	1.0814	342,874	1.0814	370,784
2023-10-10	DEBBANE RAYMOND	508,306	1.1398	508,306	1.1398	579,367
2023-09-14	WADE JEFFREY L	10,000	1.3800	10,000	1.3800	13,800
2023-08-04	McDermott Wendy	6,000	1.8400	6,000	1.8400	11,040
2023-06-29	COATS LONNEL	10,000	2.1600	10,000	2.1600	21,600

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Track Records of Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in LXRX / Lexicon Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical .

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2021-03-15	Tessmer James F	10,912	6.9043	10,912	6.9043	75,340	365	1.9500	-54,061	-71.76
2021-03-15	Tessmer James F	12,000	6.9250	12,000	6.9250	83,100
2018-06-08	Tessmer James F	10,000	12.9076	10,000	12.9076	129,076

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.